Brooks Laboratories has incorporated a wholly owned subsidiary (WOS) in the name of Abridge Speciality on July 2, 2026. The Certificate of Incorporation has been issued by the Ministry of Corporate Affairs on the same day. The incorporation of WOS aligns with the company's strategic objective to expand its business.
Brooks Laboratories is a pharmaceutical contract research and manufacturing services company.